These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Treatment of chronic hepatitis C with pegylated interferon and ribavirin in treatment-naive patients in 'true life'. Ridruejo E Eur J Gastroenterol Hepatol; 2011 Feb; 23(2):195. PubMed ID: 21228684 [No Abstract] [Full Text] [Related]
8. [Difficult-to-treat patient with chronic hepatitis C: a challenge in clinical practice]. Dou XG Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):486-7. PubMed ID: 19912678 [No Abstract] [Full Text] [Related]
9. r-Interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders. Perasso A; Testino G; Ansaldi F; Venturino V; Icardi GC Hepatology; 1999 Jan; 29(1):297-8. PubMed ID: 9935339 [No Abstract] [Full Text] [Related]
10. [Place of consensus type interferon alpha in the management of chronic type C hepatitis]. Juszczyk J Pol Merkur Lekarski; 2003 Apr; 14(82):275-8. PubMed ID: 12868183 [TBL] [Abstract][Full Text] [Related]
11. Mortality rate during interferon alfa-ribavirin combination therapy of chronic hepatitis C. Soza A; Hoofnagle JH Hepatology; 2003 Jul; 38(1):267. PubMed ID: 12830010 [No Abstract] [Full Text] [Related]
12. High-dose interferon-alpha 2b plus ribavirin combination therapy for GB virus-C/hepatitis G virus infection--a study in patients with chronic hepatitis C. Cheng PN; Jen CM; Young KC; Chen CY; Lu SN; Wang CS; Chang TT Hepatogastroenterology; 2003; 50(50):449-52. PubMed ID: 12749244 [TBL] [Abstract][Full Text] [Related]
13. [Interferon-alpha and ribavirin: advances in the therapy of chronic hepatitis C]. Zeuzem S Dtsch Med Wochenschr; 1999 May; 124(20):636-42. PubMed ID: 10370387 [No Abstract] [Full Text] [Related]
14. Phase III Peg-Intron plus Rebetol results released. AIDS Read; 2000 Dec; 10(12):702. PubMed ID: 11189740 [No Abstract] [Full Text] [Related]
15. [Peginterferon alpha combined with ribavirin for the treatment of chronic hepatitis C]. Xu Y; Wang JB Zhonghua Gan Zang Bing Za Zhi; 2011 Jun; 19(6):415-6. PubMed ID: 22053369 [No Abstract] [Full Text] [Related]
16. Viral hepatitis C. Mascitelli L; Pezzetta F Lancet; 2004 Feb; 363(9409):661. PubMed ID: 14987902 [No Abstract] [Full Text] [Related]
17. Outcome of combination antiviral therapy in hepatitis C virus infected patients with sickle cell disease. Alavian SM; Tabatabaei SV; Ayyub M Saudi Med J; 2009 Aug; 30(8):1107-8; author reply 1107-8. PubMed ID: 19668900 [No Abstract] [Full Text] [Related]
18. Combination therapy for chronic hepatitis C. Marcellin P Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):135-6. PubMed ID: 10363199 [No Abstract] [Full Text] [Related]
19. Adding ribavirin to interferon alpha-2b for chronic hepatitis C infection increased virological response and nausea. Schalm SW Gut; 1998 Nov; 43(5):602. PubMed ID: 9824337 [No Abstract] [Full Text] [Related]
20. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. McHutchison JG; Gordon SC; Schiff ER; Shiffman ML; Lee WM; Rustgi VK; Goodman ZD; Ling MH; Cort S; Albrecht JK N Engl J Med; 1998 Nov; 339(21):1485-92. PubMed ID: 9819446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]